Table 1.
Vitamins C and E (N=379) | Placebo (N=383) | ||
---|---|---|---|
Age (years) | 29·5 (5·6) | 29·6 (5·7) | |
Gestation (weeks) | 14·3 (3·6) | 14·2 (3·4) | |
Body-mass index (kg/m2) | 27·6 (5·4) | 27·4 (4·6) | |
Ethnic origin | |||
White | 364 (96%) | 371 (97%) | |
Black | 3 (1%) | 4 (1%) | |
Asian | 6 (2%) | 5 (1%) | |
Other/not known | 6 (2%) | 3 (1%) | |
12 years or fewer in full-time education | 140 (37%) | 159 (42%) | |
Primigravida | 190 (50%) | 188 (49%) | |
Blood pressure (mm Hg) | |||
Systolic | 119·2 (12·2) | 118·4 (11·6) | |
Diastolic | 74·6 (8·7) | 74·5 (8·4) | |
Antihypertensive treatment before this pregnancy | 21 (6%) | 40 (10%) | |
History of hypertension before pregnancy | 46 (12%) | 66 (17%) | |
History of pre-eclampsia in previous pregnancy | 6 (2%) | 20 (5%) | |
Diabetes | |||
Duration (years) | 14·0 (8·3) | 15·0 (8·0) | |
HbA1c at randomisation (%) | 7·2 (0·9) | 7·2 (1·0) | |
Total daily insulin dose at randomisation (units) | 58 (44–73) | 56 (43–72) | |
Renal status before this pregnancy | |||
Normal | 355 (94%) | 338 (88%) | |
Microalbuminuria | 13 (3%) | 23 (6%) | |
Macroalbuminuria | 1 (<1%) | 3 (1%) | |
24-h urinary protein more than 3 g per 24 h | 0 | 4 (1%) | |
Not known | 10 (3%) | 15 (4%) | |
Albumin-to-creatinine ratio at randomisation (mg/mmol) | 0·71 (0·38–1·28) | 0·73 (0·41–1·95) | |
Current smoker | 75 (20%) | 74 (19%) | |
Taking aspirin at randomisation | 28 (7%) | 31 (8%) | |
Taking multivitamin supplements at randomisation | 38 (10%) | 35 (9%) |
Data are mean (SD), number (%), or median (IQR).